Abstract
The single fiber electromyography (SFEMG) study is a technique developed to aid in the diagnosis of neuromuscular junction (NMJ) transmission disorders, especially myasthenia gravis (MG). It is particularly useful in cases where other test results are not sufficient for diagnosis. The goal of SFEMG is to measure impairment in NMJ transmission (manifested by increased jitter and/or blocking) which can be seen in 95–99% percent of patients with myasthenia gravis. If a SFEMG is done in a clinically weak muscle and the results are normal, then the clinician can be almost certain that the weakness is not secondary to MG or another NMJ transmission disorder.
The SFEMG study is done with either a special reusable concentric needle electrode with a small recording area 3 mm from the tip, or a disposable monopolar or concentric needle electrode with the smallest electrode surface to allow the capture of potentials from a few individual muscle fibers (preferably 2) during minimal muscle activation. Recently, the use of the disposable needle electrode has grown in popularity due to more practical aspects, including easy replacement with no need for sterilization techniques, and good accuracy and reliability of results when used with the appropriate expertise.
The action potentials for SFEMG may be obtained by mild voluntary muscle activation (which generally yields more accurate results), or by using stimulation with the help of an intramuscular needle axonal stimulator. The goal is to measure jitter and assess for NMJ transmission blocking if present, collecting 20 pairs of action potentials (each belonging to the same motor unit) from different areas of the muscle under study.
The SFEMG technique is tolerated well by most patients, and results can be easy to obtain when the performer is well-versed in the technique, the needle is in good condition, and the patient is able to cooperate well.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Single fiber EMG
- Single fiber electromyography
- Myasthenia gravis
- Needle electrode
- Jitter
- Blocking
- Neuromuscular junction
Single Fiber Electromyography
The technique of single fiber EMG (SFEMG) is mainly used to help with the diagnosis of myasthenia gravis when there is high clinical suspicion and other tests, including acetylcholine receptor, muscle specific tyrosine kinase (MuSK) antibodies and EMG with repetitive nerve stimulation have been negative.
This electrodiagnostic technique was developed in the 1960s by Erik Stalbërg and Jan Ekstedt with the purpose of obtaining action potentials from a single muscle fiber [1]. For optimal results with the single fiber EMG technique, a special concentric needle electrode with a small recording surface of 25 microns in diameter located 3 mm from the tip is used, so that it can selectively capture these action potentials from individual muscle fibers (see Figs. 11.1 and 11.2). The use of a high pass filter of 500 Hz when recording the action potentials further helps with the selectivity [3].
Acceptable action potentials are those with an amplitude of 200 microvolts or more.
More recently, monopolar and concentric needles have also been used to perform SFEMG, and reliable results can be obtained if the technique is done correctly by an experienced electromyographer. These needles have a lower cost and are disposable, eliminating the need to sterilize the needle electrode or to maintain the needle. It is recommended to increase the high pass filter to ~1000 Hz for better results. To the extent possible, a needle electrode with the smallest electrode surface should be used (e.g. 0.019 mm2).
The single fiber EMG results can be obtained by using one of two techniques:
-
1.
Stimulation SFEMG, in where individual motor fibers or motor axons can be activated using an intramuscular axonal stimulator in the form of a monopolar needle electrode positioned near the motor end-plate zone [1], which serves as the cathode, and a small surface electrode which serves as the anode.
-
2.
Voluntary activation SFEMG, in which the patient voluntarily activates the muscle to be studied.
In either technique, the goal is to measure two parameters, the neuromuscular jitter and the presence of neuromuscular blocking.
Voluntary Activity SFEMG
As the patient does minimal contraction of the muscle to be examined, the SFEMG electrode is inserted into the muscle, preferably in the middle third of its length. The electrode is then placed in a position where two (or at times more than two) time-locked action potentials from the same motor unit appear. Neuromuscular jitter is then recorded. The best recording is usually obtained from the superficial layer of the muscle and with minimal muscle contraction (firing frequency of the motor unit between 8 and 15 discharges per second) [4].
The most used muscles for SFEMG include the orbicularis oculi, extensor digitorum communis and frontalis muscle.
The voluntary activation SFEMG technique requires more patient cooperation but is subject to less technical errors or misinterpretations.
With the needle in position, the neuromuscular jitter is obtained, which is described as the minimal variability in latencies that exist between the appearance of one action potential and a second one from a single motor unit (Fig. 11.3). One action potential triggers the display sweep, and the second (paired) action potential appears with slightly variable position for each discharge [4]. This variability exists due to the changes in the transmission time across the synaptic gap, or the time it takes for end-plate potentials at the neuromuscular junction to reach the action potentials threshold [1]. Once the SFEMG electrode is in position where these action potentials are present, with adequate amplitude, then a minimum of 50 discharges need to be recorded. This technique is repeated several times, until a total of 20 action potential pairs, from different areas of the muscle, can be obtained. This may require a total of 3–4 skin insertions (aiming to minimize the number of these).
The jitter is then expressed as the mean value of consecutive differences (MCD) of successive interpotential intervals (IPIs), represented in Fig. 11.4 below.
Many of the modern electromyography machines have the capability of calculating the MCD directly, though it is always advisable that the operator visually analyzes the signals that are being acquired to asses for poor triggering or disturbing activity from other motor units and quality of the signal.
When obtaining jitter measurement and action potentials, errors can occur if the electrode is moved in relation to the fiber and the amplitude of the action potential decreases, affecting the calculated jitter.
Normal Jitters Findings and Values with Voluntary Activation
The measurement of jitter varies from muscle to muscle and with age. As age increases, so does jitter in normal subjects. Normal jitter values range from 5 to 65 microseconds, and is different to each muscle. There exist predetermined reference jitter values for the most common muscles studied with the SFEMG technique.
The value of the interpotential interval (IPI) is important and it is recommended that this stays below 4 milliseconds, as erroneous high jitter values can be obtained from recordings with long IPI [1].
The results of jitter measurements in each muscle is presented as the mean or median value of the MCD values in all the pairs or endplates measured; the percentage of paired potentials in which blocking was present (given as percentage of blocking); and the percentage of pairs in which jitter exceeds the limit of normal for that particular muscle [3].
For a study to be considered abnormal the following must be present:
-
1.
The mean (or median) jitter exceeds the upper limit of normal for the muscle; or
-
2.
More than 10% of pairs have increased jitter (including blocking).
In general, when blocking is present jitter values should already be abnormally increased. In MG gravis for example, blocking occurs during voluntary activation once jitter values exceed 80–100 μs.
A jitter value of 5 μS or less can be seen in some cases of myopathies and rarely with voluntary activation in normal muscle, this probably representing recording from split muscle fibers activated by a single NMJ. These values should not be counted for assessment of the neuromuscular transmission [3].
It is best to calculate mean MCD from individual muscles with data of jitter values less than 150 μs, as this can significantly increase mean jitter value, even if all other endplate potentials of this muscle show normal jitter values. Increase jitter, with or without blocking, can occasionally occur in one of 20 pairs in normal muscle [4].
Overall for reliable results, SFEMG must be performed by an electromyographer knowledgeable in the technique of data collection and analysis. Most patients cooperate well with this study and report relatively little discomfort. The SFEMG needle must be in good condition, with a sharp tip that prevents more than minimal muscle fiber damage.
Conditions that could limit SFEMG study include patients with limb tremor, in which the use of a facial muscle is generally preferred. Another challenging patient subgroup includes sedated patients, uncooperative patients or children under 8 or infants, in which the use stimulated SFEMG is then preferred. A decrease in intramuscular temperature below 35 °C can increase the jitter in normal muscle, so such low temperatures such be avoided.
SFEMG in Myasthenia Gravis
In patients with myasthenia gravis , the following in a tested muscle may be found:
-
1.
Endplates with normal jitter values.
-
2.
Endplates with jitter values above the normal range without impulse blocking.
-
3.
Endplates with increase jitter and intermittent impulse blocking.
Jitter is found to be increased in most patients with myasthenia gravis, and this finding is more pronounced when weak muscles are tested but can also be found in muscles that do not show clinical weakness. A SFEMG tracing showing marked jitter in a clinically affected muscle is shown in Fig. 11.5 below. Jitter is abnormal in ~85% of patients with ocular MG, and in up to ~95–99% of patients with generalized MG.
The muscle to be tested should be selected depending on patients’ symptoms, and it is preferable to select an unequivocally symptomatic muscle in order to increase the probability of finding abnormal jitter. We prefer the extensor digitorum (communis) (Fig. 11.6) in patients with generalized myasthenia gravis, and the frontalis (Fig. 11.7) or orbicularis oculus (Fig. 11.8) in patients with primarily ocular symptoms with or without generalized weakness.
The extensor digitorum is mostly tested first, and preferable in patients with limb or with bulbar muscle weakness. This muscle can be abnormal in about 85% of patients with MG during their initial electrodiagnostic assessment. This muscle is preferred due to being relatively easy to activate, with minimal patient discomfort and ease of finding pairs of action potentials. With the patient elevating the middle finger minimally, the needle is inserted parallel to the axis of the muscle fibers.
With respect to firing rate and jitter values, the jitter is most likely to be increased when the firing rate is rapid in an endplate pair, compared to when it is firing slowly.
We prefer patients discontinue the use of cholinesterase inhibitors, when clinically safe, at least 12 hours before the study. This may be more useful in patients with ocular MG or in those with minimal limb weakness as jitter can become abnormal only when these medications are discontinued. In other patients, jitter values can still be increase even when they continue to take the cholinesterase inhibitors.
If SFEMG is done in a clinically weak muscle, and jitter is normal, then the diagnosis is almost surely not MG.
In MG, jitter may not be present during initial recording of muscle activation, and measurement may need to be made for several minutes for jitter to become abnormal. This does not occur in healthy muscle, as jitter remains stable even with prolonged activation.
Jitter values do not generally correlate well with disease severity, but these values could potentially be used to monitor patients with MG, in which jitter becomes abnormal over time indicating a possible clinical exacerbation.
Abnormally increased jitter does not only occur in MG and can also be found in Lambert Eaton myasthenic syndrome (LEMS), polyneuropathies or motor neuron disorders. Therefore, it is very important to do nerve conduction studies (including repetitive nerve stimulation) and routine EMG in patients prior to SFEM, in order to exclude these diagnoses. In cases of LEMS, the jitter will be increased out of proportion to the severity of muscle weakness, and impulse blocking is commonly found. In polyneuropathies, the jitter can be increased during reinnervation, and later normalizes or reduces.
References/Suggested Reading
Sanders DB, Stålberg EV. AAEM minimonograph #25: single-fiber electromyography. Muscle Nerve. 1996;19:1069–83.
Rubin DI. Needle electromyography: basic concepts and patterns of abnormalities. Neurol Clin. 2012 May;30(2):429–56.
Stalberg E. Clinical electrophysiology in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1980;43:622–33.
Selvan VA. Single-fiber EMG: a review. Ann Indian Acad Neurol. 2011;14(1):64–7.
Meriggioli MN, Sanders DB. Myasthenia gravis: diagnosis. Semin Neurol. 2004 Mar;24(1):31–9.
Sirin NG, Kocasoy Orhan E, Durmus H, Deymeer F, Baslo MB. Repetitive nerve stimulation and jitter measurement with disposable concentric needle electrode in newly diagnosed myasthenia gravis patients. Neurophysiol Clin. 2018 Oct;48(5):261–7.
Cherian A, Baheti NN, Iype T. Electrophysiological study in neuromuscular junction disorders. Ann Indian Acad Neurol. 2013;16:134–41.
Kouyoumdjian JA, Stalberg EV. Reference jitter values for concentric needle electrodes in voluntarily activated extensor digitorum communis and orbicularis oculi muscles. Muscle Nerve. 2008;37:694–9.
Sanders DB, Howard JF. Jr AAEE Minimonograph #25: single-fiber electromyography in myasthenia gravis. Muscle Nerve. 1986;9:809–19.
Stålberg E, Sanders DB, Kouyoumdjian JA. Pitfalls and errors in measuring jitter. Clin Neurophysiol. 2017;128(11):2233–41. https://doi.org/10.1016/j.clinph.2017.09.001.
Stålberg E, Sanders DB, Ali S, Cooray G, Leonardis L, Löseth S, Machado F, Maldonado A, Martinez-Aparicio C, Sandberg A, Smith B, Widenfalk J, Kouyoumdjian JA. Reference values for jitter recorded by concentric needle electrodes in healthy controls: a multicenter study. Muscle Nerve. 2015;53(3):351–62.
Chiou-Tan FY, Gilchrist JM. Repetitive nerve stimulation and single-fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert–Eaton myasthenic syndrome: review of recent literature. Muscle Nerve. 2015;52(3):455–62.
Kouyoumdjian JA, Stålberg EV. Concentric needle jitter on voluntary activated frontalis in 20 healthy subjects. Muscle Nerve. 2013;47(3):440–2.
Juel VC. Evaluation of neuromuscular junction disorders in the electromyography laboratory. Neurol Clin. 2012;30(2):621.
Sanders DB, Howard JF, Johns TR. Single-fiber electromyography in myasthenia gravis. Neurology. 1979 Jan;29(1):68.
Machado FCN, Kouyoumdjian JA, Marchiori PE. Diagnostic accuracy of concentric needle jitter in myasthenia: prospective study. Muscle Nerve. 2016;55(2):190–4.
Baruca M, Leonardis L, Podnar S, Hojs-Fabjan T, Grad A, Jerin A, Blagus R, Šega-Jazbec S. Single fiber EMG as a prognostic tool in myasthenia gravis. Muscle Nerve. 2016;54(6):1034–40.
Kouyoumdjian JA, Stålberg EV. Concentric needle jitter on voluntary activated frontalis in 20 healthy subjects. Muscle Nerve. 2013;47(3):440–2.
Stålberg E. Jitter analysis with concentric needle electrodes. Ann N Y Acad Sci. 2012;1274(1):77–85.
Chenevier F, Gervais-Bernard H, Bouhour F, Vial C. Myasthénies et syndromes myasthéniques. EMC Neurol. 2011;8(2):1.
Tidswell T, Pitt MC. A new analytical method to diagnose congenital myasthenia with stimulated single-fiber electromyography. Muscle Nerve. 2006;35(1):107–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Soriano, A. (2021). Single Fiber EMG. In: Galvez-Jimenez, N., Soriano, A., Morren, J.A. (eds) Electrodiagnostic Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-74997-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-74997-2_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-74996-5
Online ISBN: 978-3-030-74997-2
eBook Packages: MedicineMedicine (R0)